Literature DB >> 19146804

Baroreflex device therapy in the treatment of hypertension.

Sarada C Uppuluri1, Eugene Storozynsky, John D Bisognano.   

Abstract

Despite therapy with multiple optimally dosed medications, hypertension remains poorly controlled in a sizeable number of people worldwide. This has spurred interest in exploring other pharmacologic and nonpharmacologic options for treatment. The carotid baroreceptors are important in regulating blood pressure in chronic hypertension by centrally mediated sympathoinhibitory effects and other effects. This has led to renewed interest in treating hypertension by electrically stimulating the carotid baroreceptors. Although this concept was first studied several decades ago, modern technology and better understanding of physiology have finally allowed the development of a feasible treatment option. Ongoing trials are finding significant and sustained reductions in blood pressure, a good safety profile, and tolerable side-effects. These promising results indicate that this modality has the potential to become a useful tool in future treatment of hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19146804     DOI: 10.1007/s11906-009-0013-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  23 in total

1.  Baroceptor function in chronic renal hypertension.

Authors:  J W MCCUBBIN; J H GREEN; I H PAGE
Journal:  Circ Res       Date:  1956-03       Impact factor: 17.367

2.  Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Drew A Hildebrandt; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

Review 3.  Recent insights into the interactions between the baroreflex and the kidneys in hypertension.

Authors:  Thomas E Lohmeier; Drew A Hildebrandt; Susan Warren; Paul J May; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-04       Impact factor: 3.619

4.  Prolonged activation of the baroreflex abolishes obesity-induced hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Eric D Irwin; Martin A Rossing; Robert S Kieval
Journal:  Hypertension       Date:  2007-04-16       Impact factor: 10.190

5.  Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure.

Authors:  Irving H Zucker; Johnnie F Hackley; Kurtis G Cornish; Bradley A Hiser; Nicholas R Anderson; Robert Kieval; Eric D Irwin; David J Serdar; Jacob D Peuler; Martin A Rossing
Journal:  Hypertension       Date:  2007-09-10       Impact factor: 10.190

6.  Search for optimal frequencies and amplitudes of therapeutic electrical carotid sinus nerve stimulation by application of the evolution strategy.

Authors:  T K Peters; H E Koralewski; E Zerbst
Journal:  Artif Organs       Date:  1989-04       Impact factor: 3.094

7.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

8.  Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats.

Authors:  Ling Xu; Alan F Sved
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-08       Impact factor: 3.619

9.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  5 in total

Review 1.  Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.

Authors:  Michael Doumas; Charles Faselis; Costas Tsioufis; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 2.  Baroreflex stimulation in antihypertensive treatment.

Authors:  Jeremy G Taylor; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

3.  Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension.

Authors:  James P Fisher; Paul J Fadel
Journal:  Exp Physiol       Date:  2010-03-19       Impact factor: 2.969

4.  Diagnosis and treatment of resistant hypertension: the critical role of ambulatory blood pressure monitoring.

Authors:  J Rick Turner; Eoin O'Brien
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-09-19       Impact factor: 3.738

5.  An Implanted Closed-loop Chip System for Heart Rate Control: System Design and Effects in Conscious Rats.

Authors:  Yuxuan Zhou; Yuan Yuan; Juan Gao; Ling Yang; Feng Zhang; Guoqing Zhu; Xingya Gao
Journal:  J Biomed Res       Date:  2010-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.